Answer
Blocking complement weakens defence against certain encapsulated bacteria, particularly meningococcal and pneumococcal bacteria. Vaccination reduces, but does not eliminate, this risk.
Sources for this answer
- FABHALTA 200 mg hard capsules — Current selected SmPCemc · Summary of Product Characteristics
- UK GovernmentUK Government · Reputable Web